Evidence map›Paper›PMID 30532973›Full record

ArticleJournal of the American Chemical Society2019

Chemical Interventions for the Opioid Crisis: Key Advances and Remaining Challenges.

Margaret E Olson, Lisa M Eubanks, Kim D Janda

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Opioid-Based Haptens: Development of Immunotherapy.International journal of molecular sciences · 2024
    Review
  3. Article
  4. EnantioselectiveChemical communications (Cambridge, England) · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Enhancement of a Heroin Vaccine through Hapten Deuteration.Journal of the American Chemical Society · 2020
    Article
  14. Article
  15. Cross-Institutional Collaborations to Cultivate Translational Scientists: Implications for Broadening Participation and Workforce Development in US Higher Education.Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Margaret E OlsonDepartment of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and WIRM Institute for Research and Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.ORCID 0000-0003-1865-9615
Lisa M EubanksDepartment of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and WIRM Institute for Research and Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.ORCID 0000-0001-5288-6294
Kim D JandaDepartment of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and WIRM Institute for Research and Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.ORCID 0000-0001-6759-4227

Funding

Immunopharmacotherapy for Mitigating Opioid AddictionUH3DA041146 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI JANDA, KIM · 2017 to 2019
$4.4M
Chemical Strategies to Probe the Mechanism of Liposomal Tucaresol Immunopotentiation in a Drug of Abuse VaccineF32DA044692 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI OLSON, MARGARET EMILY · 2017 to 2018
$92k
NIDA NIH HHS F32 DA044692NIDA NIH HHS UH3 DA041146
6 · The paper itself

Abstract

The present United States opioid crisis requires urgent and innovative scientific intervention. This perspective highlights a role for the chemical sciences by expounding upon three key research areas identified as priorities by the National Institute on Drug Abuse (NIDA). Specifically, important advances in chemical interventions for overdose reversal, strategies for opioid use disorder (OUD) treatment, including immunopharmacotherapies, and next-generation alternatives for pain management will be discussed. Ultimately, progress made will be presented in light of remaining challenges for the field.

Indexed as

Analgesics, OpioidDrug OverdoseHumansNational Institute on Drug Abuse (U.S.)Opioid-Related DisordersUnited StatesAnalgesics, Opioid

Identifiers

PMID30532973
PMCPMC10681095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.